Today

Agents

Chat

Arena

Discover

More

App

Vera Therapeutics CEO Fordyce Marshall disposes of USD 649,642 common shares - VERA News | Rallies

Vera Therapeutics CEO Fordyce Marshall disposes of USD 649,642 common shares

VERA•2026-09-04

Post-transaction holdings

Following the transactions, his direct Class A common stock holdings totaled 235,244 shares.

Directly held stock options totaled 507,301 shares following the transaction.

CEO sells shares and exercises options

Vera Therapeutics President and CEO Marshall Fordyce sold 18,500 Class A common shares on Sep. 2 at a sale price of USD 35.12 per share.

He also exercised options for 18,500 shares at USD 2.9 per share.

Related News

Arrive AI files draft information statement for Nevada redomestication

ARAI•2026-09-04

Dollar Tree director Stephanie Stahl disposes of 1,185 shares worth $155,791.95

DLTR•2026-09-04

Advanced Flower Capital director Leonard M. Tannenbaum buys $54,649 of common shares

Sources

S

Vera Therapeutics CEO Fordyce Marshall disposes of USD 649,642 common shares

Sec

AFCG

•

2026-09-04

Vistance Networks director L. William Krause disposes of 23,864 common shares worth $149,537

VISN•2026-09-04

SCWorx risks Nasdaq delisting after falling below minimum publicly held shares requirement

WORX•2026-09-04